Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer (Q39439833)

12 September 2017

Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer (English)

1 reference

12 September 2017

1 reference

1 reference

Junqing Chen

1

1 reference

12 September 2017

Wei Tian

2

1 reference

12 September 2017

Hongke Cai

3

1 reference

12 September 2017

Haifei He

4

1 reference

12 September 2017

Yongchuan Deng

5

1 reference

12 September 2017

19 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

29

1 reference

12 September 2017

4

1 reference

12 September 2017

2527-2534

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-011-0117-4

12 September 2017

0 references

cites work

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Biomarkers and multiple drug resistance in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

PKD2 mediates multi-drug resistance in breast cancer cells through modulation of P-glycoprotein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Role of microRNA in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0117-4

miRNA-34a is associated with docetaxel resistance in human breast cancer cells

21 January 2018

1 reference

12 December 2020

The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

1 reference

12 December 2020

MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer

1 reference

12 December 2020

E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells

1 reference

12 December 2020

10.1007/S12032-011-0117-4

Identifiers

DOI

1 reference

12 September 2017

1 reference